Literature DB >> 25633850

Taming glutamate excitotoxicity: strategic pathway modulation for neuroprotection.

Ming Jia1, Steve A Noutong Njapo, Vaibhav Rastogi, Vishnumurthy Shushrutha Hedna.   

Abstract

Much work has been carried out in recent years showing that elevated glutamate levels in the extracellular environment of the central nervous system play a pivotal role in neurodegeneration in acute CNS injuries. With the elucidation of the mechanism governing glutamate excitotoxicity, researchers are devising therapeutic strategies to target different parts of the pathway which begins with glutamate accumulation and ultimately results in neuronal cell death. In this article, we review some of the major classes of agents that are currently being investigated and highlight some of the key studies for each. Glutamate scavenging is a relatively new approach that directly decreases glutamate levels in the brain, thus preventing excitotoxicity. Nitric oxide inhibitors and free radical scavengers are more well-studied strategies that continue to yield promising results.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25633850     DOI: 10.1007/s40263-015-0225-3

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  89 in total

1.  Pyruvate's blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke.

Authors:  Matthew Boyko; Alexander Zlotnik; Benjamin F Gruenbaum; Shaun E Gruenbaum; Sharon Ohayon; Ruslan Kuts; Israel Melamed; Adi Regev; Yoram Shapira; Vivian I Teichberg
Journal:  Eur J Neurosci       Date:  2011-09-21       Impact factor: 3.386

2.  Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction.

Authors:  Masahiro Mishina; Yuichi Komaba; Shiro Kobayashi; Nobuyuki Tanaka; Shushi Kominami; Takaharu Fukuchi; Takayuki Mizunari; Makoto Hamamoto; Akira Teramoto; Yasuo Katayama
Journal:  Neurol Med Chir (Tokyo)       Date:  2005-07       Impact factor: 1.742

Review 3.  Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?

Authors:  Margarida V Caldeira; Ivan L Salazar; Michele Curcio; Lorella M T Canzoniero; Carlos B Duarte
Journal:  Prog Neurobiol       Date:  2013-10-22       Impact factor: 11.685

Review 4.  Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.

Authors:  Keith W Muir
Journal:  Curr Opin Pharmacol       Date:  2005-12-15       Impact factor: 5.547

5.  Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95.

Authors:  Li Zhou; Fei Li; Hai-Bing Xu; Chun-Xia Luo; Hai-Yin Wu; Ming-Mei Zhu; Wei Lu; Xing Ji; Qi-Gang Zhou; Dong-Ya Zhu
Journal:  Nat Med       Date:  2010-11-21       Impact factor: 53.440

6.  Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death.

Authors:  H Manev; M Favaron; A Guidotti; E Costa
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

Review 7.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

Authors:  Chrysanthy Ikonomidou; Lechoslaw Turski
Journal:  Lancet Neurol       Date:  2002-10       Impact factor: 44.182

8.  Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model.

Authors:  A M Palmer; D W Marion; M L Botscheller; P E Swedlow; S D Styren; S T DeKosky
Journal:  J Neurochem       Date:  1993-12       Impact factor: 5.372

9.  Blood glutamate scavenging as a novel neuroprotective treatment for paraoxon intoxication.

Authors:  Angela Ruban; Boaz Mohar; Ghil Jona; Vivian I Teichberg
Journal:  J Cereb Blood Flow Metab       Date:  2013-10-23       Impact factor: 6.200

10.  Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia.

Authors:  M Pérez-Mato; P Ramos-Cabrer; T Sobrino; M Blanco; A Ruban; D Mirelman; P Menendez; J Castillo; F Campos
Journal:  Cell Death Dis       Date:  2014-01-09       Impact factor: 8.469

View more
  17 in total

Review 1.  Role of astrocyte-synapse interactions in CNS disorders.

Authors:  Elena Blanco-Suárez; Alison L M Caldwell; Nicola J Allen
Journal:  J Physiol       Date:  2016-08-08       Impact factor: 5.182

Review 2.  Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy.

Authors:  Karol Chojnowski; Mikolaj Opielka; Wojciech Nazar; Przemyslaw Kowianski; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

Review 3.  Neuronal Cell Death.

Authors:  Michael Fricker; Aviva M Tolkovsky; Vilmante Borutaite; Michael Coleman; Guy C Brown
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 4.  The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.

Authors:  Edward Pajarillo; Asha Rizor; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  Neuropharmacology       Date:  2019-03-06       Impact factor: 5.250

Review 5.  Pharmacological Enhancement of Stroke Recovery.

Authors:  Amit Kumar; Tomoko Kitago
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-30       Impact factor: 5.081

Review 6.  A novel mechanism of neuroprotection: Blood glutamate grabber.

Authors:  José Castillo; María Isabel Loza; David Mirelman; José Brea; Miguel Blanco; Tomás Sobrino; Francisco Campos
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

7.  Synthesis and biological evaluation of memantine nitrates as a potential treatment for neurodegenerative diseases.

Authors:  Zheng Liu; Si Yang; Xiaoyong Jin; Gaoxiao Zhang; Baojian Guo; Haiyun Chen; Pei Yu; Yewei Sun; Zaijun Zhang; Yuqiang Wang
Journal:  Medchemcomm       Date:  2016-10-20       Impact factor: 3.597

8.  Perillyl alcohol decreases the frequency and severity of convulsive-like behavior in the adult zebrafish model of acute seizures.

Authors:  Arlindo César Matias Pereira; Brenda Lorena Sánchez-Ortíz; Ester Lopes de Melo; Lorane Izabel da Silva Hage-Melim; Raphaelle Sousa Borges; Xuebo Hu; José Carlos Tavares Carvalho
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-30       Impact factor: 3.000

Review 9.  Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson's Disease.

Authors:  Xiang Li; Wenjun Wang; Jianghong Yan; Fancai Zeng
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

10.  Unveiling a key role of oxaloacetate-glutamate interaction in regulation of respiration and ROS generation in nonsynaptic brain mitochondria using a kinetic model.

Authors:  Vitaly A Selivanov; Olga A Zagubnaya; Yaroslav R Nartsissov; Marta Cascante
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.